Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Nussenzveig

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Clinical Chemistry|January 31, 2012
CommentaryArchana M Agarwal, Roberto Nussenzveig
The Lancet. Oncology|November 13, 2018
Biomarkers in renal-cell carcinoma: building on clinical paradigmsNeeraj Agarwal, Roberto Nussenzveig, Sumanta K Pal
Pharmacogenomics|December 19, 2019
Germline variants and response to systemic therapy in advanced prostate cancerEric Johnson, Roberto Nussenzveig, Neeraj Agarwal, et al.
Trends in Cancer|June 15, 2020
Advanced Prostate Cancer: Treatment Advances and Future DirectionsUmang Swami, Taylor R McFarland, Roberto Nussenzveig, et al.
Drugs|December 28, 2020
Evolving Role of Immunotherapy in Metastatic Castration Refractory Prostate CancerNityam Rathi, Taylor Ryan McFarland, Roberto Nussenzveig, et al.
Experimental Hematology|March 24, 2007
In vitro expansion of erythroid progenitors from polycythemia vera patients leads to decrease in JAK2 V617F alleleAmos Gaikwad, Roberto Nussenzveig, Enli Liu, et al.
Cancer Treatment and Research Communications|February 12, 2019
Evolution of the genomic landscape of circulating tumor DNA (ctDNA) in metastatic prostate cancer over treatment and timeAndrew W Hahn, David Stenehjem, Roberto Nussenzveig, et al.
Blood Cells, Molecules & Diseases|June 2, 2009
Genetic adaptation to extreme hypoxia: study of high-altitude pulmonary edema in a three-generation Han Chinese familyV Felipe Lorenzo, Yingzhong Yang, Tatum S Simonson, et al.
Clinical Genitourinary Cancer|September 30, 2017
Incidence and Characterization of Antiandrogen Withdrawal Syndrome After Discontinuation of Treatment With Enzalutamide in Castration-resistant Prostate CancerAustin Poole, David Gill, Andrew W Hahn, et al.
Blood Cells, Molecules & Diseases|February 26, 2011
Molecular basis of two novel mutations found in type I methemoglobinemiaFelipe R Lorenzo, John D Phillips, Roberto Nussenzveig, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Clinical Chemistry|January 31, 2012
CommentaryArchana M Agarwal, Roberto Nussenzveig
The Lancet. Oncology|November 13, 2018
Biomarkers in renal-cell carcinoma: building on clinical paradigmsNeeraj Agarwal, Roberto Nussenzveig, Sumanta K Pal
Pharmacogenomics|December 19, 2019
Germline variants and response to systemic therapy in advanced prostate cancerEric Johnson, Roberto Nussenzveig, Neeraj Agarwal, et al.
Trends in Cancer|June 15, 2020
Advanced Prostate Cancer: Treatment Advances and Future DirectionsUmang Swami, Taylor R McFarland, Roberto Nussenzveig, et al.
Drugs|December 28, 2020
Evolving Role of Immunotherapy in Metastatic Castration Refractory Prostate CancerNityam Rathi, Taylor Ryan McFarland, Roberto Nussenzveig, et al.
Experimental Hematology|March 24, 2007
In vitro expansion of erythroid progenitors from polycythemia vera patients leads to decrease in JAK2 V617F alleleAmos Gaikwad, Roberto Nussenzveig, Enli Liu, et al.
Cancer Treatment and Research Communications|February 12, 2019
Evolution of the genomic landscape of circulating tumor DNA (ctDNA) in metastatic prostate cancer over treatment and timeAndrew W Hahn, David Stenehjem, Roberto Nussenzveig, et al.
Blood Cells, Molecules & Diseases|June 2, 2009
Genetic adaptation to extreme hypoxia: study of high-altitude pulmonary edema in a three-generation Han Chinese familyV Felipe Lorenzo, Yingzhong Yang, Tatum S Simonson, et al.
Clinical Genitourinary Cancer|September 30, 2017
Incidence and Characterization of Antiandrogen Withdrawal Syndrome After Discontinuation of Treatment With Enzalutamide in Castration-resistant Prostate CancerAustin Poole, David Gill, Andrew W Hahn, et al.
Blood Cells, Molecules & Diseases|February 26, 2011
Molecular basis of two novel mutations found in type I methemoglobinemiaFelipe R Lorenzo, John D Phillips, Roberto Nussenzveig, et al.
Pageof 3